NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Corundum Neuroscience

Corundum Neuroscience

Herzliyacnsfund.com

Overview

Corundum Neuroscience is a neuroscience-focused venture builder and fund that works with researchers and entrepreneurs to build and grow companies developing solutions for health and disease areas, including anxiety, depression, PTSD, chronic pain, sleep, and neurodegenerative disorders.

Year Founded

2023

Portfolio Companies

10

Investments

Corundum Neuroscience investments
CompanyDateStageLead
NeuraWorx Medical TechnologiesDec 2025SeedCo-investor
NextSense, Inc.Nov 2025Series ACo-investor
NextSenseNov 2025Series ACo-investor
NextSens TechnologyNov 2025Series ACo-investor
Pheno.AINov 2024VC RoundCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersHerzliya
Year Founded2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.